ITC Begins Section 337 Investigation on Botulinum Products
The International Trade Commission has officially begun its Section 337 investigation into imported botulinum products. The investigation follows a March 30 complaint by Medytox (see 2204040058), which alleged theft and conversion and misappropriation of trade secrets by Hugel and Croma.…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
The complaint alleges that Hugel develops and manufactures botulinum toxin products using a proprietary strain of botulinum bacteria and trade secrets stolen from Medytox, which Croma then distributes in the U.S. Medytox is requesting a permanent limited exclusion order and a permanent cease and desist order.